RESISTANT CANCER

Clinical trials for RESISTANT CANCER explained in plain language.

Never miss a new study

Get alerted when new RESISTANT CANCER trials appear

Sign up with your email to follow new studies for RESISTANT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New drug targets tough cancers in Mid-Stage trial

Disease control Ongoing

This study tests an experimental drug called 9-ING-41, which blocks a protein (GSK-3β) that helps cancers grow. It is given alone or with chemotherapy to 350 adults with advanced or hard-to-treat cancers like pancreatic, breast, lung, or bone cancer. The goal is to see if the dru…

Matched conditions: RESISTANT CANCER

Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control

Last updated May 17, 2026 00:41 UTC

RESISTANT CANCER

Get alerted when new RESISTANT CANCER trials appear

New drug targets tough cancers in Mid-Stage trial